青松健康
693136.40+0.10+0.28%收盤・資料日 2026-11-06
每股盈餘左軸 EPS、右軸股價
2026 Q22.20 元—
單季 EPS（元）
202120222023202420252026
盈餘表新到舊
| 季別 | EPS（元） | 季增率 | 年增率 |
|---|---|---|---|
| 2026 Q2 | 2.20 | +348.98% | +511.11% |
| 2026 Q1 | 0.49 | −19.67% | — |
| 2026 Q1–Q2 合計 | 2.69 | +767.74% | |
| 2025 Q4 | 0.61 | +29.79% | +154.17% |
| 2025 Q3 | 0.47 | +30.56% | +261.54% |
| 2025 Q2 | 0.36 | — | +12.50% |
| 2025 Q1 | −0.05 | −120.83% | — |
| 2025 全年合計 | 1.39 | — | |
| 2024 Q4 | 0.24 | +84.62% | −58.62% |
| 2024 Q3 | 0.13 | −59.38% | — |
| 2024 Q2 | 0.32 | — | −36.00% |
| 2023 Q4 | 0.58 | — | +314.29% |
| 2023 Q2 | 0.50 | — | +66.67% |
| 2022 Q4 | 0.14 | — | — |
| 2022 Q2 | 0.30 | — | — |
| 2021 Q4 | −0.05 | — | −110.20% |
三率
2026 Q216.24%7.09%46.68%
三率（%）
202120222023202420252026
三率明細單季
| 期間 | 毛利率 | 營益率 | 淨利率 |
|---|---|---|---|
| 2026 Q2 | 16.24% | 7.09% | 46.68% |
| 2026 Q1 | 15.24% | 8.04% | 11.06% |
| 2025 Q4 | 15.66% | 7.38% | 14.18% |
| 2025 Q3 | 12.63% | 5.14% | 11.28% |
| 2025 Q2 | 13.21% | 5.45% | 8.26% |
| 2025 Q1 | 10.83% | 1.99% | −1.49% |
| 2024 Q4 | 13.51% | 4.68% | 5.80% |
| 2024 Q3 | 13.20% | 4.95% | 2.93% |
| 2024 Q2 | 11.78% | 4.13% | 3.90% |
| 2023 Q4 | 14.91% | 8.21% | 7.19% |
| 2023 Q2 | 11.36% | 3.85% | 6.30% |
| 2022 Q4 | 11.30% | 3.20% | 2.89% |
| 2022 Q2 | 8.88% | 0.91% | 2.93% |
| 2021 Q4 | 7.50% | −1.11% | 0.06% |
ROE 拆解每季都是近四季合計
2026 Q2近四季
ROE21.45%
＝淨利率21.45%
×總資產週轉0.47 次
×權益乘數2.14 倍
ROA 9.83%。
2026 Q221.45%9.83%
ROE、ROA（近四季合計，%）
202120222023202420252026
2026 Q221.45%
淨利率（近四季，%）
202120222023202420252026
2026 Q20.47 次
總資產週轉（近四季合計，次）
202120222023202420252026
2026 Q22.14 倍
權益乘數（倍）
202120222023202420252026
ROE 明細每季都是近四季合計
| 期間 | ROE | ROA | 淨利率 | 總資產週轉（次） | 權益乘數（倍） |
|---|---|---|---|---|---|
| 2026 Q2 | 21.45% | 9.83% | 21.45% | 0.47 | 2.14 |
| 2026 Q1 | 11.46% | 5.18% | 11.23% | 0.46 | 2.21 |
| 2025 Q4 | 8.17% | 3.70% | 8.35% | 0.46 | 2.11 |
| 2025 Q3 | 6.73% | 2.82% | — | 0.48 | — |
| 2025 Q2 | 4.98% | 1.93% | — | 0.50 | — |
| 2025 Q1 | 5.65% | 1.95% | — | 0.63 | — |